SANOFI US SERVICES INC. for SANOFI US SERVICES INC
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Copyright/Patent/Trademark CPT
Issues related to Compulsory Licensing; issues related to drug patents; and issues related to S. 2082 "Support Technology and Research for Our Nation's Growth and Economic Resilience Patents Act of 2019".
Foreign entity interest: Sanofi US Services Inc. is owned by Sanofi SA and to the degree that public policies, either laws or regulations, commercially benefit Sanofi US Services Inc., so too Sanofi SA, as the parent corporation, will benefit.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MARYANNE DOLBEARE DUNLAP | — |
| JUAN MACHADO | — |
| AMY L REDL | — |
| ELIZABETH STOWER | — |
Trade (domestic/foreign) TRD
Issues related to USMCA- United States- Mexico-Canada Agreement.
Foreign entity interest: Sanofi US Services Inc is owned by Sanofi SA and to the degree that public policies, either laws or regulations, commercially benefit Sanofi US Services Inc., so too Sanofi SA, as the parent corporation, will benefit.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MARYANNE DOLBEARE DUNLAP | — |
| ELIZABETH STOWER | — |
Health Issues HCR
Issues related to the HHS Rebate rule; general issues related to drug pricing; issues related to cosmetic regulations; issues related to insulin pricing;issues related to s.102 "Prescription Drug Price Relief Act of 2019"; issues related to International Reference pricing; issues related to OTC Monograph Reform; issues related to Arbitration;; issues related to S.1379 " Pandemic and All Hazards Preparedness and Advancing Innovation Act of 2019"; issues related to H.R. 269 "Pandemic and All Hazards Preparedness and Advancing Innovation Act of 2019; issues related to prescription to over-the-counter switch; issues related to compulsory licensing; issues related to Drug Importation; and issues related to H.R. 3 "Lower Drug Costs Now Act of 2019".
Foreign entity interest: Sanofi US Services Inc. is owned by Sanofi SA and to the degree that public policies, either laws or regulations, commercially benefit Sanofi US Services Inc., so too Sanofi SA, as the parent corporation, will benefit.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MARYANNE DOLBEARE DUNLAP | — |
| JUAN MACHADO | — |
| KATIE OPPENHEIM | — |
| AMY L REDL | — |
| ELIZABETH STOWER | — |
Medicare/Medicaid MMM
Issues related to blended ASP authorized generics; issues related to Medicaid AMP CAP; issues related to international price index; and issues related to Medicare Part D.
Foreign entity interest: Sanofi US Services Inc is owned by Sanofi SA and to the degree that public policies, either laws or regulations, commercially benefit Sanofi US Services Inc., so too Sanofi SA, as the parent corporation, will benefit.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MARYANNE DOLBEARE DUNLAP | — |
| JUAN MACHADO | — |
| KATIE OPPENHEIM | — |
| AMY L REDL | — |
| ELIZABETH STOWER | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.